Label: EPINEPHRINE 0.15 PEDIATRICS injection

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application Authorized Generic

Drug Label Information

Updated December 3, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Epinephrine injection, USP auto-injectors are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include ...
  • 2 DOSAGE AND ADMINISTRATION
    2.1 Recommended Dosage According to Patient Body Weight - Patients greater than or equal to 30 kg (approximately 66 pounds or more): epinephrine injection, USP auto-injector, 0.3 mg - Patients 15 ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Injection: 0.3 mg (0.3 mg/0.3 mL), clear and colorless solution in single-dose pre-filled auto-injector - Injection: 0.15 mg (0.15 mg/0.3 mL), clear and colorless solution in single-dose pre-filled ...
  • 4 CONTRAINDICATIONS
    None
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Emergency Treatment - Epinephrine injection, USP auto-injectors are intended for immediate administration as emergency supportive therapy and are not intended as a substitute for immediate ...
  • 6 ADVERSE REACTIONS
    Due to the lack of randomized, controlled clinical trials of epinephrine for the treatment of anaphylaxis, the true incidence of adverse reactions associated with the systemic use of epinephrine ...
  • 7 DRUG INTERACTIONS
    Cardiac Glycosides, Diuretics, and Anti-arrhythmics - Patients who receive epinephrine while concomitantly taking cardiac glycosides, diuretics, or anti-arrhythmics should be observed carefully ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no adequate and well controlled studies of the acute effect of epinephrine in pregnant women. In animal reproductive studies, epinephrine administered ...
  • 10 OVERDOSAGE
    Overdosage of epinephrine may produce extremely elevated arterial pressure, which may result in cerebrovascular hemorrhage, particularly in elderly patients. Overdosage may also result in ...
  • 11 DESCRIPTION
    Epinephrine injection, USP auto-injectors, 0.3 mg and 0.15 mg, are single-dose auto-injectors and combination products containing drug and device components. Each epinephrine injection, USP ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Epinephrine acts on both alpha- and beta-adrenergic receptors. 12.2 Pharmacodynamics - Through its action on alpha-adrenergic receptors, epinephrine lessens the ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Long-term studies to evaluate the carcinogenic potential of epinephrine have not been conducted. Epinephrine and other catecholamines ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    How Supplied - Epinephrine Injection, USP Auto-Injectors, 0.3 mg 2-Pak is supplied with 2 single-dose pre-filled auto-injectors and 1 auto-injector trainer device: 0.3 mg/0.3 mL (NDC ...
  • 17 PATIENT COUNSELING INFORMATION
    See FDA-Approved Patient Labeling ( Patient Information and Instructions for Use). A healthcare provider should review the patient instructions and operation of epinephrine injection ...
  • PATIENT INFORMATION and INSTRUCTIONS FOR USE
    Epinephrine Injection [/eh-puh-neh-fruhn/], USP Auto-Injector 0.3 mg - one dose of 0.3 mg epinephrine, USP 0.3 mg/0.3 mL - Epinephrine Injection [/eh-puh-neh-fruhn/], USP Auto-Injector 0.15 mg ...
  • Epinephrine Injection, USP Auto-Injector Trainer
    Instructions for Use - In an emergency: Do not use the gray Trainer. Use your real yellow epinephrine injection, USP auto-injector, 0.3 mg or real green epinephrine injection, USP auto-injector ...
  • PRINCIPAL DISPLAY PANEL – 0.3 mg
    NDC 49502-102-02 - Rx only - Epinephrine Injection, USP - Single-Dose Auto-Injectors 0.3 mg - For Allergic Emergencies (Anaphylaxis) Each carton contains: Two Epinephrine Injection ...
  • PRINCIPAL DISPLAY PANEL – 0.15 mg
    NDC 49502-101-02 - Rx only - Epinephrine Injection, USP - Single-Dose Auto-Injectors 0.15 mg - For Allergic Emergencies (Anaphylaxis) This carton contains: Two Epinephrine Injection, USP ...
  • INGREDIENTS AND APPEARANCE
    Product Information